Abstract
Patients with chronic heart failure have prolonged sympathetic stimulation and subsequent worsening of the failing heart function. Beta-blockers (non-selective, cardio-selective, and non-selective with ancillary properties) counteract the effects of prolonged sympathetic stimulation. Beta-blocker therapy results in the improvement of the left ventricular systolic and diastolic function, reversal remodeling, heart rate control, effective prevention of the malignant arrhythmias, and lowering of the both cardiac afterload and preload in patients with chronic heart failure.
Keywords: Beta-blockers, mechanisms, childhood, heart failure.
Reviews on Recent Clinical Trials
Title:Mechanisms of Beta-Blockers Action in Patients with Heart Failure
Volume: 9 Issue: 2
Author(s): Sergej Prijic and Reiner Buchhorn
Affiliation:
Keywords: Beta-blockers, mechanisms, childhood, heart failure.
Abstract: Patients with chronic heart failure have prolonged sympathetic stimulation and subsequent worsening of the failing heart function. Beta-blockers (non-selective, cardio-selective, and non-selective with ancillary properties) counteract the effects of prolonged sympathetic stimulation. Beta-blocker therapy results in the improvement of the left ventricular systolic and diastolic function, reversal remodeling, heart rate control, effective prevention of the malignant arrhythmias, and lowering of the both cardiac afterload and preload in patients with chronic heart failure.
Export Options
About this article
Cite this article as:
Prijic Sergej and Buchhorn Reiner, Mechanisms of Beta-Blockers Action in Patients with Heart Failure, Reviews on Recent Clinical Trials 2014; 9 (2) . https://dx.doi.org/10.2174/1574887109666140908125402
DOI https://dx.doi.org/10.2174/1574887109666140908125402 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
Current Drug Safety iNOS: A Potential Therapeutic Target for Malignant Glioma
Current Molecular Medicine Obstructive Sleep Apnea Syndrome: From Phenotype to Genetic Basis
Current Genomics Estrogen Receptor-Positive and Estrogen Receptor-Negative Human Breast Cancer Cells: Regulation of Expression of Cancer-Related Genes by Estradiol and Tamoxifen
Current Signal Transduction Therapy Microbial / Enzymatic Synthesis of Chiral Intermediates for Pharmaceuticals: Case Studies from BMS
Current Organic Chemistry The Role of Trimetazidine After Acute Myocardial Infarction
Current Vascular Pharmacology Optimal Management of Hypertension in patients with Ischemic Heart Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry HIF-1α and Calcium Signaling as Targets for Treatment of Prostate Cancer by Cardiac Glycosides
Current Cancer Drug Targets Tracking Stem Cell Therapy in the Myocardium: Applications of Positron Emission Tomography
Current Pharmaceutical Design The Role of Obesity in Cardiomyopathy and Nephropathy
Current Pharmaceutical Design Polymer Structures for Sensors and Actuators 1. Analyte Biosensor
Recent Patents on Materials Science Effect of Cardiovascular Injury on Catabolism of Adenosine and Adenosine 5-‘Triphosphate in Systemic Blood in a Freely Moving Rat Model In Vivo
Drug Metabolism Letters The Risks and Benefits of Therapy with Aldosterone Receptor Antagonist Therapy
Current Drug Safety Altering the Sphingosine-1-Phosphate/Ceramide Balance: A Promising Approach for Tumor Therapy
Current Pharmaceutical Design Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design Advances on PPARγ Research in the Emerging Era of Precision Medicine
Current Drug Targets Chronic Inhibition of Na+/H+-Exchanger in the Heart
Current Vascular Pharmacology Hyperhomocysteinaemia: A Critical Review of Old and New Aspects
Current Drug Metabolism The Role of Endothelin System in Cardiovascular Disease and the Potential Therapeutic Perspectives of its Inhibition
Current Topics in Medicinal Chemistry Variability in Response to Cardiovascular Drugs
Current Clinical Pharmacology